Document Preview Unavailable

Targeting HIV-1 with CRISPR/Cas9 delivered by retargeted adenoviruses effectively suppresses viral replication

Klinnert, Sarah; Freitag, Patrick C; Plueckthun, Andreas; Metzner, Karin J.  bioRxiv, Dec 18, 2023.

You might have access to this document